Expression of tissue inhibitors of metalloproteinase 1 (TIMP-1) in gastric cancer tissue

被引:17
作者
Mroczko, Barbara [1 ]
Lukaszewicz-Zajac, Marta [1 ]
Groblewska, Magdalena [1 ]
Czyzewska, Jolanta [2 ]
Gryko, Mariusz [3 ]
Guzinska-Ustymowicz, Katarzyna [4 ]
Kemona, Andrzej [4 ]
Kedra, Boguslaw [3 ]
Szmitkowski, Maciej [1 ]
机构
[1] Med Univ, Dept Biochem Diagnost, PL-15269 Bialystok, Poland
[2] Med Univ, Dept Clin Lab Diagnost, PL-15269 Bialystok, Poland
[3] Med Univ, Dept Gen Surg 2, PL-15269 Bialystok, Poland
[4] Med Univ, Dept Gen Pathomorphol, PL-15269 Bialystok, Poland
关键词
gastric cancer; tissue inhibitor of matrix metalloproteinase 1; MATRIX METALLOPROTEINASES; COLORECTAL-CANCER; CARCINOMA; TUMOR;
D O I
10.2478/v10042-009-0071-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Degradation of extracellular matrix (ECM) is an essential step of invasion and metastasis of gastric cancer. The proteolysis of basement membranes depends on the balance between activities of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). The aim of the study was to assess the expression of TIMP-1 in gastric cancer (GC) and interstitial inflammatory infiltrate cells within GC tissue in relation to clinico-pathological features of tumor and to estimate the prognostic significance of TIMP-1 expression for patients' survival. The presence of TIMP-1 in 54 cases of gastric cancer samples was investigated by immunohistochemistry. The expression of TIMP-1 in cancer and interstitial inflammatory infiltrate cells was evaluated in semi-quantitative scale. The immunoreactivity of TIMP-1 in cancer and inflammatory cells was positive in 100% of cases and varied from weak to intense reaction. The intensity of TIMP-1 expression increased with more advanced tumor stages and in patients who died of cancer during 2-year observation. TIMP-1 expression in interstitial inflammatory infiltrate cells was the independent prognostic factor for patients' survival. The results suggest the role of TIMP-1 in gastric tumorigenesis, although this issue requires further investigtions.
引用
收藏
页码:511 / 516
页数:6
相关论文
共 50 条
  • [41] Serum TIMP-1 in gastric cancer patients: A potential prognostic biomarker
    Wang, CS
    Wu, TL
    Tsao, KC
    Sun, CF
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2006, 36 (01) : 23 - 30
  • [42] The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients
    Mroczko, Barbara
    Groblewska, Magdalena
    Okulczyk, Bogna
    Kedra, Boguslaw
    Szmitkowski, Maciej
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (10) : 1177 - 1184
  • [43] The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients
    Barbara Mroczko
    Magdalena Groblewska
    Bogna Okulczyk
    Bogusław Kędra
    Maciej Szmitkowski
    International Journal of Colorectal Disease, 2010, 25 : 1177 - 1184
  • [44] TFF1 antagonizes TIMP-1 mediated proliferative functions in gastric cancer
    Omar, Omar M.
    Soutto, Mohammed
    Bhat, Nadeem S.
    Bhat, Ajaz A.
    Lu, Heng
    Chen, Zheng
    El-Rifai, Wael
    MOLECULAR CARCINOGENESIS, 2018, 57 (11) : 1577 - 1587
  • [45] Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma
    Alpizar-Alpizar, Warner
    Laerum, Ole Didrik
    Christensen, Ib J.
    Ovrebo, Kjell
    Skarstein, Arne
    Hoyer-Hansen, Gunilla
    Ploug, Michael
    Illemann, Martin
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2016, 64 (08) : 483 - 494
  • [46] VEGF and metalloproteinase 2 (MMP 2) expression in gastric cancer tissue
    Partyka, R.
    Jalowiecki, P.
    Kokocinska, D.
    9TH INTERNATIONAL GASTRIC CANCER CONGRESS (IGCC 2011): A GATE TO THE FUTURE OF GASTRIC CANCER TREATMENT, 2011, : 195 - 200
  • [47] VEGF and metalloproteinase 2 (MMP 2) expression in gastric cancer tissue
    Partyka, Robert
    Gonciarz, Maciej
    Jalowiecki, Przemyslaw
    Kokocinska, Danuta
    Byrczek, Tomasz
    MEDICAL SCIENCE MONITOR, 2012, 18 (04): : BR130 - BR134
  • [48] Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas
    Tomasz Krecicki
    Marcin Fraczek
    Michal Jelen
    Marzena Podhorska
    Teresa Szkudlarek
    Tomasz Zatonski
    European Archives of Oto-Rhino-Laryngology, 2003, 260 : 494 - 497
  • [49] Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas
    Krecicki, T
    Fraczek, M
    Jelen, M
    Podhorska, M
    Szkudlarek, T
    Zatonski, T
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2003, 260 (09) : 494 - 497
  • [50] Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer
    Öberg, Å
    Höyhtyä, M
    Tavelin, B
    Stenling, R
    Lindmark, G
    ANTICANCER RESEARCH, 2000, 20 (2B) : 1085 - 1091